SCHEMBL20006085

SCHEMBL20006085

CCN1C(=O)/C(=C/c2ccccc2OC(C)C)SC1=S

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.51
▸ KMT2A Q03164 9/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ MAPT P10636 3/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ IDE P14735 1/20 0.51
▸ ALOX12 P18054 1/20 0.51
▸ TNNI3 P19429 1/20 0.51
▸ TNNT2 P45379 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ TNNC1 P63316 1/20 0.51
▸ PDE4B Q07343 2/20 0.49
▸ POLB P06746 3/20 0.48
▸ PPARG P37231 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ CTNNB1 P35222 1/20 0.47
▸ TCF7L2 Q9NQB0 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18103090 1.00 MEN1 (0.51) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL12008535 0.85 CTNNB1 (0.68) MEN1KMT2AALDH1A1MAPTPOLB
SCHEMBL18102996 0.79 MEN1 (0.54) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL8205507 0.79 CTNNB1 (0.73) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL8205510 0.79 CTNNB1 (0.73) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL8205465 0.78 PDE4B (0.62) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL8205466 0.78 PDE4B (0.62) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL19999128 0.78 PDE4B (0.62) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL23600233 0.77 FFAR1 (0.64) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL2447134 0.75 CISD1 (0.67) MEN1KMT2AALDH1A1MAPTPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 — — US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 MEN1 846/4885KMT2A 470/4885ALDH1A1 2177/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 MEN1 846/4885KMT2A 470/4885ALDH1A1 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback